TorHoerman Law offers free, no-obligation case consultations for all potential clients
Average participant ages ranged from 7 to 50 years
Second, GLP-1 slows gastric emptying, meaning food leaves the stomach more gradually
People with higher body weight Body weight influences drug distribution and can affect the perceived strength of a starting dose
Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisks Wegovy pill received approval in December
Coryell Health doesnt recommend taking GLP-1 medications if you: Are pregnant or breastfeeding Have a personal or family history of medullary thyroid cancer (MTC) Have a diagnosis of multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal conditions Side effects of taking a GLP-1 medication may include: Loss of appetite Nausea and vomiting Diarrhea Dizziness Mildly increased heart rate Pancreatitis Medullary thyroid cancer (MTC) Acute kidney injury If youre unsure whether an existing condition, your personal history or your family history will not mix well with a GLP-1 medication, talk with your Coryell Health primary care provider to determine whether a GLP-1 medication is right for you